Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
4.900
-0.170 (-3.35%)
Nov 21, 2024, 2:38 PM EST - Market open
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $91.40 million as of November 21, 2024. Its market cap has decreased by -42.50% in one year.
Market Cap
91.40M
Enterprise Value
77.40M
1-Year Change
-42.50%
Ranking
Category
Stock Price
$4.90
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $91.40M, an increase of 57.57%. That is a compound annual growth rate of 17.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 95.87M | -33.65% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 100.43M |
| Anixa Biosciences | 100.40M |
| Adagene | 98.28M |
| Assembly Biosciences | 97.48M |
| Karyopharm Therapeutics | 96.87M |
| Coherus BioSciences | 94.65M |
| Immunic | 94.58M |
| FONAR | 94.45M |